---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-070883"
form_type: "8-K"
ticker: "CVKD"
cik: "0001937993"
company_name: "Cadrenal Therapeutics, Inc."
filed_at: "2024-08-20T23:59:59+00:00"
generated_at: "2026-05-31T08:33:05.765104+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cadrenal Therapeutics effects 1-for-15 reverse stock split to meet Nasdaq $1 minimum bid price

## Summary
- Reverse stock split at 1-for-15 effective 12:01 a.m. ET on August 20, 2024; shares reduced from ~16 million to ~1.1 million.
- No fractional shares issued; holders of fractional shares receive cash based on 10-day average closing price before effective time.
- Split intended to bring common stock (CVKD) into compliance with Nasdaq's $1.00 minimum bid price requirement.
- New CUSIP number for common stock is 127636207; proportional adjustments made to outstanding equity awards and warrants.

## SEC filing metadata
- accession: 0001213900-24-070883
- form_type: 8-K
- ticker: CVKD
- cik: 0001937993
- company_name: Cadrenal Therapeutics, Inc.
- filed_at: 2024-08-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1937993/000121390024070883/0001213900-24-070883-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1937993/000121390024070883/ea021179601-8k_cadrenal.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-070883
- JSON: https://secwatch.observer/filing/0001213900-24-070883.json
- Plain text: https://secwatch.observer/filing/0001213900-24-070883.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.